Talk:Morphine/naltrexone
Appearance
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Morphine/naltrexone.
|
the article uses the words "Was", it still is an active drug. — Preceding unsigned comment added by KingSparta (talk • contribs) 22:29, 25 February 2015 (UTC)
"FDA has approved an updated label for EMBEDA"
[edit]Pfizer press release 10/17/2014
Apparently Embeda is currently back on the market with new label and "boxed warning", and the non-tamper-resistant morphine ER (Avinza) is being discontinued (at least in USA?).
"Pfizer has decided to remove its non-abuse deterrent morphine formulation, AVINZA® (morphine sulfate) extended-release capsules CII from the U.S. market and notified the FDA earlier this year of the intent to discontinue manufacturing of the product."